Overexpression of adenosine A2A receptors in rats: Effects on depression, locomotion, and anxiety

Frontiers in Psychiatry

Volumn 5, Issue JUN, 2014, Pages

  Coelho, Joana E ^a   Alves, Pedro ^a   Canas, Paula M ^b,c   Valadas, Jorge S ^a   Shmidt, Tatiana ^d   Batalha, Vânia L ^a   Ferreira, Diana G ^a   Ribeiro, Joaquim A ^a   Bader, Michael ^d   Cunha, Rodrigo A ^b,c   do Couto, Frederico Simões ^a   Lopes, Luísa V ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Adenosine A2A receptors; Anxiety; Depression; Dopamine; Locomotion; Memory; Stress

Indexed keywords

ADENOSINE A2A RECEPTOR;

ADULT; ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; EXPLORATORY BEHAVIOR; FORCED SWIM TEST; LOCOMOTION; MALE; MOLECULAR PATHOLOGY; MOTIVATION; NONHUMAN; OPEN FIELD TEST; PROTEIN EXPRESSION; RAT; SUCROSE PREFERENCE TEST; WILD TYPE;

EID: 84904513530     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2014.00067     Document Type: Article

References (86)

1. Sebastião AM, Ribeiro JA. Adenosine receptors and the central nervous system. Handb Exp Pharmacol (2009) (193):471-534.
2. Rétey JV, Adam M, Gottselig JM, Khatami R, Dürr R, Achermann P, et al. Adenosinergic mechanisms contribute to individual differences in sleep deprivation-induced changes in neurobehavioral function and brain rhythmic activity. J Neurosci (2006) 26(41):10472-9. doi: 10.1523/JNEUROSCI.1538-06.2006
3. Elmenhorst D, Meyer PT, Winz OH, Matusch A, Ermert J, Coenen HH, et al. Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study. J Neurosci (2007) 27(9):2410-5. doi:10.1523/JNEUROSCI.5066-06.2007
4. Boison D. Adenosine dysfunction and adenosine kinase in epileptogenesis. Open Neurosci J (2010) 4:93-101. doi:10.2174/1874082001004020093
5. Van Dycke A, Raedt R, Dauwe I, Sante T, Wyckhuys T, Meurs A, et al. Continuous local intrahippocampal delivery of adenosine reduces seizure frequency in rats with spontaneous seizures. Epilepsia (2010) 51(9):1721-8. doi:10.1111/j.1528-1167.2010.02700.x
6. Lam P, Hong CJ, Tsai SJ. Association study of A2a adenosine receptor genetic polymorphism in panic disorder. Neurosci Lett (2005) 378(2):98-101. doi:10.1016/j.neulet.2004.12.012
7. Alsene K, Deckert J, Sand P, de Wit H. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology (2003) 28(9):1694-702. doi:10.1038/sj.npp.1300232
8. Albasanz JL, Perez S, Barrachina M, Ferrer I, Martín M. Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease. Brain Pathol (2008) 18(2):211-9. doi:10.1111/j.1750-3639.2007.00112.x
9. Hurley MJ, Mash DC, Jenner P. Adenosine A(2A) receptor mRNA expression in Parkinson's disease. Neurosci Lett (2000) 291(1):54-8. doi:10.1016/S0304-3940(00)01371-9
10. Urigüen L, García-Fuster MJ, Callado LF, Morentin B, La Harpe R, Casadó V, et al. Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment. Psychopharmacology (2009) 206(2):313-24. doi:10.1007/s00213-009-1608-2
11. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J. International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev (2001) 53(4):527-52.
12. Ribeiro JA, Sebastião AM, de Mendonca A. Adenosine receptors in the nervous system: pathophysiological implications. Prog Neurobiol (2002) 68(6):377-92. doi:10.1016/S0301-0082(02)00155-7
13. Girault JA, Greengard P. The neurobiology of dopamine signaling. Arch Neurol (2004) 61(5):641-4. doi:10.1001/archneur.61.5.641
14. Bjorklund A, Dunnett SB. Dopamine neuron systems in the brain: an update. Trends Neurosci (2007) 30(5):194-202. doi:10.1016/j.tins.2007.03.006
15. Pierce RC, Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev (2006) 30(2):215-38. doi:10.1016/j.neubiorev.2005.04.016
16. Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III - the final common pathway. Schizophr Bull (2009) 35(3):549-62. doi:10.1093/schbul/sbp006
17. Pizzagalli DA, Holmes AJ, Dillon DG, Goetz EL, Birk JL, Bogdan R, et al. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry (2009) 166(6):702-10. doi:10.1176/appi.ajp.2008.08081201
18. Keedwell PA, Andrew C, Williams SC, Brammer MJ, Phillips ML. The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry (2005) 58(11):843-53. doi:10.1016/j.biopsych.2005.05.019
19. Wacker J, Dillon DG, Pizzagalli DA. The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques. Neuroimage (2009) 46(1):327-37. doi:10.1016/j.neuroimage.2009.01.058
20. Sadock J, Sadock A, Ruiz P. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 9th ed. (Vol. 2). Philadelphia: Lippincott Williams & Wilkins (2009). p. 1875-6.
21. Korchounov A, Meyer MF, Krasnianski M. Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation. J Neural Transm (2010) 117(12):1359-69. doi:10.1007/s00702-010-0454-z
22. Meyer JH, McNeely HE, Sagrati S, Boovariwala A, Martin K, Verhoeff NP, et al. Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study. Am J Psychiatry (2006) 163(9):1594-602. doi:10.1176/appi.ajp.163.9.1594
23. Ferré S, Fredholm BB, Morelli M, Popoli P, Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci (1997) 20(10):482-7. doi:10.1016/S0166-2236(97)01096-5
24. Fuxe K, Ferré S, Genedani S, Franco R, Agnati LF. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol Behav (2007) 92(1-2):210-7. doi:10.1016/j.physbeh.2007.05.034
25. Muscat R, Willner P. Suppression of sucrose drinking by chronic mild unpredictable stress: a methodological analysis. Neurosci Biobehav Rev (1992) 16(4):507-17. doi:10.1016/S0149-7634(05)80192-7
26. Rygula R, Abumaria N, Flügge G, Fuchs E, Rüther E, Havemann-Reinecke U. Anhedonia and motivational deficits in rats: impact of chronic social stress. Behav Brain Res (2005) 162(1):127-34. doi:10.1016/j.bbr.2005.03.009
27. Yan HC, Cao X, Das M, Zhu XH, Gao TM. Behavioral animal models of depression. Neurosci Bull (2010) 26(4):327-37. doi:10.1007/s12264-010-0323-7
28. Brooks SP, Dunnett SB. Tests to assess motor phenotype in mice: a user's guide. Nat Rev Neurosci (2009) 10(7):519-29. doi:10.1038/nrn2652
29. Choleris E, Thomas AW, Kavaliers M, Prato FS. A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci Biobehav Rev (2001) 25(3):235-60. doi:10.1016/S0149-7634(01)00011-2
30. Popova EA, Krivokharchenko AS, Vil'ianovich LI. In vitro development of murine embryos using different types of microinjections. Ontogenez (2002) 33:107-10. doi:10.1023/A:1014912128311
31. Mayford M, Bach ME, Kandel E. CaMKII function in the nervous system explored from a genetic perspective. Cold Spring Harb Symp Quant Biol (1996) 61:219-24. doi:10.1101/SQB.1996.061.01.024
32. Batalha VL, Pego JM, Fontinha BM, Costenla AR, Valadas JS, Baqi Y, et al. Adenosine A2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation. Mol Psychiatry (2013) 18:320-31. doi:10.1038/mp.2012.8
33. Strekalova T, Spanagel R, Bartsch D, Henn FA, Gass P. Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology (2004) 29(11):2007-17. doi:10.1038/sj.npp.1300532
34. Bekris S, Antoniou K, Daskas S, Papadopoulou-Daifoti Z. Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. Behav Brain Res (2005) 161(1):45-59. doi:10.1016/j.bbr.2005.01.005
35. Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature (1977) 266(5604):730-2. doi:10.1038/266730a0
36. Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci (2002) 23(5):238-45. doi:10.1016/S0165-6147(02)02017-5
37. Detke MJ, Rickels M, Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (1995) 121(1):66-72. doi:10.1007/BF02245592
38. Castagne V, Porsolt RD, Moser P. Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse. Eur J Pharmacol (2009) 616(1-3):128-33. doi:10.1016/j.ejphar.2009.06.018
39. Papp M, Willner P, Muscat R. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology (1991) 104(2):255-9. doi:10.1007/BF02244188
40. Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA, et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry (2009) 14(8):764-73, 739. doi:10.1038/mp.2008.119
41. Simões do Couto F, Batalha VL, Valadas JS, Franco J, Ribeiro JA, Lopes LV. Escitalopram improves memory deficits induced by maternal separation in the rat. Eur J Pharmacol (2012) 695(1-3):71. doi:10.1016/j.ejphar.2012.08.020
42. Cryan JF, Valentino RJ, Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev (2005) 29(4-5):547-69. doi:10.1016/j.neubiorev.2005.03.008
43. El Yacoubi M, Costentin J, Vaugeois JM. Adenosine A2A receptors and depression. Neurology (2003) 61(11 Suppl 6):S82-7. doi:10.1212/01.WNL.0000095220.87550.F6
44. Kaster MP, Rosa AO, Rosso MM, Goulart EC, Santos AR, Rodrigues AL. Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A receptors. Neurosci Lett (2004) 355(1-2):21-4. doi:10.1016/j.neulet.2003.10.040
45. Lobato KR, Binfaré RW, Budni J, Rosa AO, Santos AR, Rodrigues AL. Involvement of the adenosine A1 and A2A receptors in the antidepressant-like effect of zinc in the forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry (2008) 32(4):994-9. doi:10.1016/j.pnpbp.2008.01.012
46. Castañé A, Soria G, Ledent C, Maldonado R, Valverde O. Attenuation of nicotine-induced rewarding effects in A2A knockout mice. Neuropharmacology (2006) 51(3):631-40. doi:10.1016/j.neuropharm.2006.05.005
47. Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ, et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature (1997) 388(6643):674-8. doi:10.1038/41771
48. Karcz-Kubicha M, Antoniou K, Terasmaa A, Quarta D, Solinas M, Justinova Z, et al. Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsychopharmacology (2003) 28(7):1281-91. doi:10.1038/sj.npp.1300167
49. Jain N, Kemp N, Adeyemo O, Buchanan P, Stone TW. Anxiolytic activity of adenosine receptor activation in mice. Br J Pharmacol (1995) 116(3):2127-33. doi:10.1111/j.1476-5381.1995.tb16421.x
50. Collins LE, Galtieri DJ, Collins P, Jones SK, Port RG, Paul NE, et al. Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: effects on locomotor activity. Behav Brain Res (2010) 211(2):148-55. doi:10.1016/j.bbr.2010.03.003
51. Braun AR, Laruelle M, Mouradian MM. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications. J Neural Transm (1997) 104(4-5):341-62. doi:10.1007/BF01277656
52. Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol (2003) 463(1-3):3-33. doi:10.1016/S0014-2999(03)01272-X
53. Giménez-Llort L, Schiffmann SN, Shmidt T, Canela L, Camón L, Wassholm M, et al. Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain. Neurobiol Learn Mem (2007) 87(1):42-56. doi:10.1016/j.nlm.2006.05.004
54. Wei CJ, Augusto E, Gomes CA, Singer P, Wang Y, Boison D, et al. Regulation of fear responses by striatal and extrastriatal adenosine A2A receptors in forebrain. Biol Psychiatry (2013) 75(11):855-63. doi:10.1016/j.biopsych.2013.05.003
55. El Yacoubi M, Ledent C, Parmentier M, Costentin J, Vaugeois JM. The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists. Psychopharmacology (2000) 148(2):153-63. doi:10.1007/s002130050037
56. Schiffmann SN, Fisone G, Moresco R, Cunha RA, Ferré S. Adenosine A2A receptors and basal ganglia physiology. Prog Neurobiol (2007) 83(5):277-92. doi:10.1016/j.pneurobio.2007.05.001
57. Millan MJ, Brocco M, Papp M, Serres F, La Rochelle CD, Sharp T, et al. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole. J Pharmacol Exp Ther (2004) 309(3):936-50.
58. McAuley JD, Stewart AL, Webber ES, Cromwell HC, Servatius RJ, Pang KC. Wistar-Kyoto rats as an animal model of anxiety vulnerability: support for a hypervigilance hypothesis. Behav Brain Res (2009) 204(1):162-8. doi:10.1016/j.bbr.2009.05.036
59. Ramos A. Animal models of anxiety: do I need multiple tests? Trends Pharmacol Sci (2008) 29(10):493-8. doi:10.1016/j.tips.2008.07.005
60. Bilbao A, Cippitelli A, Martín AB, Granado N, Ortiz O, Bezard E, et al. Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice. Psychopharmacology (2006) 185(2):160-8. doi:10.1007/s00213-005-0284-0
61. Brown RM, Short JL, Cowen MS, Ledent C, Lawrence AJ. A differential role for the adenosine A2A receptor in opiate reinforcement vs opiate-seeking behavior. Neuropsychopharmacology (2009) 34(4):844-56. doi:10.1038/npp.2008.72
62. Soria G, Castañé A, Ledent C, Parmentier M, Maldonado R, Valverde O. The lack of A2A adenosine receptors diminishes the reinforcing efficacy of cocaine. Neuropsychopharmacology (2006) 31(5):978-87. doi:10.1038/sj.npp.1300876
63. Yu C, Gupta J, Chen JF, Yin HH. Genetic deletion of A2A adenosine receptors in the striatum selectively impairs habit formation. J Neurosci (2009) 29(48):15100-3. doi:10.1523/JNEUROSCI.4215-09.2009
64. Jutkiewicz EM, Baladi MG, Folk JE, Rice KC, Woods JH. The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-met hoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats. J Pharmacol Exp Ther (2008) 324(2):714-24. doi:10.1124/jpet.107.123844
65. Katsuura Y, Taha SA. Modulation of feeding and locomotion through mu and delta opioid receptor signaling in the nucleus accumbens. Neuropeptides (2010) 44(3):225-32. doi:10.1016/j.npep.2009.12.002
66. Kuzmin A, Madjid N, Terenius L, Ogren SO, Bakalkin G. Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice. Neuropsychopharmacology (2006) 31(9):1928-37. doi:10.1038/sj.npp.1300959
67. Li FW, Deurveilher S, Semba K. Behavioural and neuronal activation after microinjections of AMPA and NMDA into the perifornical lateral hypothalamus in rats. Behav Brain Res (2011) 224(2):376-86. doi:10.1016/j.bbr.2011.06.021
68. Garção P, Szabó EC, Wopereis S, Castro AA, Tomé ÂR, Prediger RD, et al. Functional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum. Br J Pharmacol (2013) 169(7):1600-11. doi:10.1111/bph.12234
69. Gomes CA, Simões PF, Canas PM, Quiroz C, Sebastião AM, Ferré S, et al. GDNF control of the glutamatergic cortico-striatal pathway requires tonic activation of adenosine A receptors. J Neurochem (2009) 108(5):1208-19. doi:10.1111/j.1471-4159.2009.05876.x
70. Zhao H, Ohinata K, Yoshikawa M. Central prostaglandin D(2) exhibits anxiolytic-like activity via the DP(1) receptor in mice. Prostaglandins Other Lipid Mediat (2009) 88(3-4):68-72. doi:10.1016/j.prostaglandins.2008.10.001
71. Listos J, Malec D, Fidecka S. Influence of adenosine receptor agonists on benzodiazepine withdrawal signs in mice. Eur J Pharmacol (2005) 523(1-3):71-8. doi:10.1016/j.ejphar.2005.07.025
72. Lopes LV, Cunha RA, Ribeiro JA. Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats. J Neurophysiol (1999) 82(3):196-203.
73. Lopes LV, Cunha RA, Kull B, Fredholm BB, Ribeiro JA. Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition. Neuroscience (2002) 112:319-29. doi:10.1016/S0306-4522(02)00080-5
74. Ciruela F, Casadó V, Rodrigues RJ, Luján R, Burgueño J, Canals M, et al. Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci (2006) 26:2080-7. doi:10.1523/JNEUROSCI.3574-05.2006
75. Rebola N, Rodrigues RJ, Lopes LV, Richardson PJ, Oliveira CR, Cunha RA. Adenosine A1 and A2A receptors are co-expressed in pyramidal neurons and co-localized in glutamatergic nerve terminals of the rat hippocampus. Neuroscience (2005) 133:79-83. doi:10.1016/j.neuroscience.2005.01.054
76. Matos M, Augusto E, Santos-Rodrigues AD, Schwarzschild MA, Chen JF, Cunha RA, et al. Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes. Glia (2012) 60(5):702-16. doi:10.1002/glia.22290
77. Costenla AR, Diógenes MJ, Canas PM, Rodrigues RJ, Nogueira C, Maroco J, et al. Enhanced role of adenosine A(2A) receptors in the modulation of LTP in the rat hippocampus upon ageing. Eur J Neurosci (2011) 34:12-21. doi:10.1111/j.1460-9568.2011.07719.x
78. Short JL, Ledent C, Drago J, Lawrence AJ. Receptor crosstalk: characterization of mice deficient in dopamine D1 and adenosine A2A receptors. Neuropsychopharmacology (2006) 31(3):525-34. doi:10.1038/sj.npp.1300852
79. Simon P, Panissaud C, Costentin J. Anxiogenic-like effects induced by stimulation of dopamine receptors. Pharmacol Biochem Behav (1993) 45(3):685-90. doi:10.1016/0091-3057(93)90525-X
80. D'Aquila PS, Collu M, Pani L, Gessa GL, Serra G. Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression. Eur J Pharmacol (1994) 262(1-2):107-11.
81. Hirano S, Miyata S, Onodera K, Kamei J. Involvement of dopamine D1 receptors and alpha1-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test. Eur J Pharmacol (2007) 562(1-2):72-6. doi:10.1016/j.ejphar.2007.01.063
82. Yao L, Arolfo MP, Dohrman DP, Jiang Z, Fan P, Fuchs S, et al. beta gamma Dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption. Cell (2002) 109(6):733-43. doi:10.1016/S0092-8674(02)00763-8
83. Dassesse D, Massie A, Ferrari R, Ledent C, Parmentier M, Arckens L, et al. Functional striatal hypodopaminergic activity in mice lacking adenosine A(2A) receptors. J Neurochem (2001) 78(1):183-98. doi:10.1046/j.1471-4159.2001.00389.x
84. Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, Fredholm BB, et al. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci U S A (2000) 97(4):1856-60. doi:10.1073/pnas.97.4.1856
85. Rodrigues RJ, Alfaro TM, Rebola N, Oliveira CR, Cunha RA. Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum. J Neurochem (2005) 92(3):433-41. doi:10.1111/j.1471-4159.2004.02887.x
86. Li X, Need AB, Baez M, Witkin JM. Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice. J Pharmacol Exp Ther (2006) 319(1):254-9. doi:10.1124/jpet.106.103143